PLIN2: A Protein Involved in Cellular Signaling and Disease (G123)

Target Name: PLIN2

NCBI ID: G123

PLIN2

PLIN2: A Protein Involved in Cellular Signaling and Disease

PLIN2 (Perilipin 2) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and blood vessels. It is a member of the P1 subfamily of the phospholipid binding proteins (P1Ps) and is characterized by its ability to interact with different types of phospholipids, including phosphatidylcholine (PC) and phosphatidylserine (PS).

PLIN2 is involved in a variety of cellular processes that are important for proper physiological function. One of its main functions is to regulate the level of phospholipids in different cell types, which is critical for maintaining the structural integrity of cells and facilitating their signaling processes. PLIN2 is also involved in the regulation of cellular signaling pathways, including the production of reactive oxygen species (ROS) and the detoxification of environmental toxins.

In addition to its role in cellular signaling, PLIN2 is also a potential drug target. Researchers have identified several potential small molecules that can interact with PLIN2 and are currently exploring their potential as potential therapeutic agents. One of the most promising of these small molecules is a compound called WQ1, which is a natural product derived from the essential oil of thyme.

WQ1 has been shown to interact with PLIN2 and can inhibit the activity of PLIN2 in cell culture experiments. This suggests that WQ1 may be a useful tool for studying the effects of PLIN2 inhibitors on cellular signaling pathways. Furthermore, animal studies have shown that administration of WQ1 has led to a reduction in the expression of PLIN2 in rat brain tissue, which may indicate that PLIN2 is a target of the WQ1.

Another potential drug target for PLIN2 is a small molecule called R186. R186 is a synthesized compound that is similar to WQ1 and has been shown to interact with PLIN2 in cell culture experiments. R186 has been shown to inhibit the activity of PLIN2 in a similar way to WQ1 and may be a useful tool for studying the effects of PLIN2 inhibitors on cellular signaling pathways.

PLIN2 is also a potential biomarker for a variety of diseases. For example, PLIN2 has been shown to be expressed in the brains of individuals with Alzheimer's disease, a condition characterized by the progressive accumulation of neurofibrillary tangles and beta-amyloid plaques in the brain. This suggests that PLIN2 may be a useful biomarker for the diagnosis and treatment of Alzheimer's disease.

In addition to its potential drug and biomarker applications, PLIN2 is also of interest as a potential therapeutic target for a variety of other diseases. For example, PLIN2 has been shown to be involved in the regulation of cellular signaling pathways that are involved in inflammation, fibrosis, and cancer. This suggests that PLIN2 may be a useful target for the development of new therapeutic agents for these diseases.

In conclusion, PLIN2 is a protein that is involved in a variety of cellular processes that are important for proper physiological function. Its role in the regulation of phospholipid levels and cellular signaling pathways makes PLIN2 a potential drug target and a useful biomarker for a variety of diseases. Further research is needed to fully understand the functions of PLIN2 and its potential as a therapeutic agent.

Protein Name: Perilipin 2

Functions: Structural component of lipid droplets, which is required for the formation and maintenance of lipid storage droplets

The "PLIN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLIN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets